Annelotte van Bommel

173 General discussion and future perspectives REFERENCES 1. Siesling S, Tjan-Heijnen VC, de Roos M, et al., Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands. Breast Cancer Res Treat, 2014. 147: p. 177-84. 2. Dutch Health Care Inspectorate [Breast cancer care is reliable]. October 2010. 3. NABONBreastCancerAudit .nbca.clinicalaudit.nl . 4. GooikerGA,VeerbeekL,vanderGeestLG,etal., The quality indicator ‘tumour positive surgical margin following breast conserving surgery’ does not provide transparent insight into care. NedTijdschrGeneeskd2010;154:A1142. 5. Sandelin K, National Breast Cancer Quality Register: A Powerful Tool to Improve Treatment. www.hkbcf.org/document/ ProfSandelin_eng.pdf. 6. Royal Australasian College of Surgeons. BreastSurgANZ Quality Audit. www. surgeons.org/research-audit/morbidity- audits/morbidity-audits-managed-by-racs/ breastsurganz-quality-audit. 7. Association of Breast Surgery, association ofbreastsurgery.org.uk/audit/absnational- audits/. 8. Kamali P, van Bommel A, Becherer B, et al., Immediate Breast Reconstruction in The NetherlandsandtheUnitedStates:AProof-of- Concept to Internationally Compare Quality of CareUsingCancerRegistryData.PlastReconstr Surg 2019;144:565e-574. 9. Comprehensive Cancer Organization the Netherlands (IKNL). www.iknl.nl . 10. DutchInstituteforClinicalAuditing(DICA) .dica.nl. 11. van Bommel AC, Spronk PE, Vrancken Peeters MT, et al. Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer Audit. J SurgOncol. 2017;115:243–249. 12. Schreuder K, Maduro JH, Spronk PER, et al., Variation intheUseofBoost Irradiation inBreast conservingTherapyintheNetherlands:TheEffect of a National Guideline and Cofounding Factors. ClinOncol(RCollRadiol)2019;31:250-259. 13. Poodt IGM,SpronkPER,VugtsG,etal.,Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg 2018;268:1084-1090. 14. SpronkPER,vanBommelACM,SieslingS,etal., Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit. Breast 2017;36:34-38. 15. National Breast Cancer Organization of the Netherlands, [Guideline breast cancer], www. oncoline.nl . 16. Lobbes MB, Vriens IJ, van Bommel AC, et al., Breast MRI increases the number of mastectomiesforductalcancers,butdecreases them for lobular cancers. Breast Cancer Res Treat. 2017;162:353-364. 17. Vriens IJH, Keymeulen K, Lobbes MBI, et al., Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers. Eur J Cancer 2017;81:74-80. 9